SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-007161
Filing Date
2023-04-28
Accepted
2023-04-28 10:38:34
Documents
8
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20230608xdef14a.htm DEF 14A 1180537
2 GRAPHIC tmb-20230608xdef14a_a001.jpg GRAPHIC 10297
3 GRAPHIC tmb-20230608xdef14a_a002.jpg GRAPHIC 7911
4 GRAPHIC tmb-20230608xdef14a_a004.jpg GRAPHIC 7936
5 GRAPHIC tmb-20230608xdef14a_a011.jpg GRAPHIC 68638
6 GRAPHIC tmb-20230608xdef14a_a012.jpg GRAPHIC 69571
7 GRAPHIC tmb-20230608xdef14a_bg001.jpg GRAPHIC 110217
8 GRAPHIC tmb-20230608xdef14a_bg002.jpg GRAPHIC 103538
  Complete submission text file 0001558370-23-007161.txt   1703346
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36464 | Film No.: 23861434
SIC: 2834 Pharmaceutical Preparations